Optos P200TE Agreement and Precision Study
Not Applicable
Completed
- Conditions
- GlaucomaRetinal Disease
- Registration Number
- NCT03868462
- Lead Sponsor
- Optos, PLC
- Brief Summary
This study is a prospective comparative, randomized, single center study to assess agreement and precision of the Optos P200TE in comparison to the predicate device in normal subjects, subjects with glaucoma, and subjects with retinal disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 137
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Precision between the Optos P200TE and predicate device measurements of optic disc (area, volume, cup-to-disc ratio). At the end of Visit 1 or optional Visit 2 (each visit is 1 day) Precision between the Optos P200TE and predicate device measurements of full retinal thickness. At the end of Visit 1 or optional Visit 2 (each visit is 1 day) Precision of the P200TE for the super pixel grid measurements of GCC thickness. At the end of Visit 1 or optional Visit 2 (each visit is 1 day) Limit of Agreement (LOA) between the Optos P200TE and predicate device measurements of full retinal thickness (μm). At the end of Visit 1 or optional Visit 2 (each visit is 1 day) Limit of Agreement (LOA) between the Optos P200TE and predicate device measurements of ganglion cell complex thickness (μm). At the end of Visit 1 or optional Visit 2 (each visit is 1 day) Precision between the Optos P200TE and predicate device measurements of ganglion cell complex thickness. At the end of Visit 1 or optional Visit 2 (each visit is 1 day) Limit of Agreement (LOA) between the Optos P200TE and predicate device measurements of retinal nerve fiber layer thickness (μm). At the end of Visit 1 or optional Visit 2 (each visit is 1 day) Precision of the P200TE for the super pixel grid measurements of the RNFL thickness. At the end of Visit 1 or optional Visit 2 (each visit is 1 day) Limit of Agreement (LOA) between the Optos P200TE and predicate device measurements of optic disc (area, volume, cup-to-disc ratio). At the end of Visit 1 or optional Visit 2 (each visit is 1 day) Precision between the Optos P200TE and predicate device measurements of retinal nerve fiber layer thickness. At the end of Visit 1 or optional Visit 2 (each visit is 1 day) Precision of the P200TE for the super pixel grid measurements of the full retinal thickness. At the end of Visit 1 or optional Visit 2 (each visit is 1 day)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie glaucoma progression in NCT03868462 Optos P200TE study participants?
How does Optos P200TE imaging compare to standard-of-care OCT in detecting retinal disease biomarkers?
What biomarkers are associated with retinal disease severity in the NCT03868462 clinical trial?
Are there specific adverse events reported with Optos P200TE in glaucoma patients compared to traditional imaging methods?
What are the key differences in diagnostic precision between Optos P200TE and other retinal imaging technologies for early glaucoma detection?
Trial Locations
- Locations (1)
New England Retina Consultants
🇺🇸Springfield, Massachusetts, United States
New England Retina Consultants🇺🇸Springfield, Massachusetts, United States